Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03260842 · ClinicalTrials.gov registry record
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
A clinical trial of Pancreatic Cyst and Pancreas Disease, sponsored by Stanford University.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT03260842: Recruiting study of Pancreatic Cyst and Pancreas Disease, sponsored by Stanford University.
NCT03260842 is a study of Pancreatic Cyst and Pancreas Disease that is actively recruiting participants, run by Stanford University. The registered enrollment target is 500 participants, roughly in line with the 522-participant average among 18 other Pancreatic Cyst trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03260842, a study of Pancreatic Cyst and Pancreas Disease, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Bio-repository to collect bio-specimens from patients with 1) pancreatic cysts and 2) patients at high risk, defined by family history and/or genetic mutations, for pancreatic cancer.
Primary Outcome
Development of Pancreas Cancer
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Bio-Specimen Collection
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2030-04-30 |
What NCT03260842 shows while recruiting
NCT03260842 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 522-participant average among 18 other Pancreatic Cyst trials with a reported enrollment target.
The record links to 2 conditions, with Pancreatic Cyst appearing as the primary indexed condition, and to 1 intervention - of which Bio-Specimen Collection is the first listed.
NCT03260842 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03260842 about?
NCT03260842 is a clinical study titled "Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer". Bio-repository to collect bio-specimens from patients with 1) pancreatic cysts and 2) patients at high risk, defined by family history and/or genetic mutations, for pancreatic cancer.
What is the current status of trial NCT03260842?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2017-09-01. Estimated completion is 2030-04-30.
What conditions does trial NCT03260842 study?
This clinical trial studies the following conditions: Pancreatic Cyst, Pancreas Disease.
What interventions are being tested in trial NCT03260842?
The interventions under investigation include: Bio-Specimen Collection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03260842?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03260842 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cyst
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03260842's enrollment target sits among peer trials
500 5th of 18 higher than 13 of 18 other Pancreatic Cyst trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatic Cyst trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
RECRUITING
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies
RECRUITING · NA
-
UCSF PANC Cyst Registry
RECRUITING
-
PROMs After Pancreatectomy
RECRUITING
-
Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI